NANOG and breast cancer: Consistently, tumors from breast cancer patients with low butyric acid displayed lower ZFP36 mRNA and higher LRP5/NANOG/SOX2/Ki67 mRNA compared with patients with high butyric acid (Fig. 6k, l and Supplementary Fig. 8w–y).